{"id":"NCT04446299","sponsor":"Braintree Laboratories","briefTitle":"Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy","officialTitle":"A Safety and Efficacy Comparison of BLI4900 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-07-13","primaryCompletion":"2020-12-22","completion":"2021-01-22","firstPosted":"2020-06-24","resultsPosted":"2023-10-24","lastUpdate":"2023-11-07"},"enrollment":519,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"SINGLE","primaryPurpose":"TREATMENT"},"conditions":["Colonoscopy"],"interventions":[{"type":"DRUG","name":"Bowel Prep","otherNames":[]}],"arms":[{"label":"BLI4900","type":"EXPERIMENTAL"},{"label":"FDA Approved Control","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to compare the safety and efficacy of BLI4900 bowel preparation to an FDA-approved control as 2-day, split-dose bowel preparations prior to colonoscopy in adult patients.","primaryOutcome":{"measure":"Proportion of Subjects With Successful Bowel Preparation","timeFrame":"2 days","effectByArm":[{"arm":"BLI4900","deltaMin":215,"sd":null},{"arm":"FDA Approved Control","deltaMin":212,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":16},"locations":{"siteCount":25,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":233},"commonTop":["Nausea","Abdominal distension","Vomiting","Abdominal Pain","Headache"]}}